Cornerstone Planning Group’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.73K Sell
35
-25
-42% -$3.03K ﹤0.01% 1166
2026
Q1
$8.37K Buy
60
+22
+58% +$3.38K ﹤0.01% 950
2025
Q4
$5.92K Hold
38
﹤0.01% 937
2025
Q3
$7.38K Hold
38
﹤0.01% 847
2025
Q2
$4.24K Sell
38
-20
-34% -$1.53K ﹤0.01% 761
2025
Q1
$4.11K Buy
58
+8
+16% +$612 ﹤0.01% 784
2024
Q4
$3.88K Sell
50
-11
-18% -$792 ﹤0.01% 633
2024
Q3
$4.33K Hold
61
﹤0.01% 593
2024
Q2
$4.34K Buy
61
+55
+917% +$2.13K ﹤0.01% 606
2024
Q1
$154 Hold
6
﹤0.01% 1026
2023
Q4
$186 Hold
6
﹤0.01% 868
2023
Q3
$152 Buy
+6
New +$137 ﹤0.01% 1058

Other funds holding INSM

Cornerstone Planning Group's INSM Position: Q2 2026 in Review

Cornerstone Planning Group reduced its Insmed (INSM) stake by 42% in Q2 2026, selling an estimated $3.03K and leaving 35 shares worth $3.73K. The position accounts for ﹤0.01% of the portfolio, ranked #1166.

Cornerstone Planning Group first reported a position in INSM in Q3 2023 and has held it in 12 quarters since. The position peaked at $8.37K in Q1 2026. 312 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Cornerstone Planning Group held 35 shares of Insmed worth $3.73K as of Q2 2026.
  • Cornerstone Planning Group sold 25 Insmed shares in Q2 2026, an estimated $3.03K.
  • Insmed made up ﹤0.01% of Cornerstone Planning Group's portfolio in Q2 2026, its #1166 holding.
  • Cornerstone Planning Group first reported a position in Insmed in Q3 2023 and has held it in 12 quarters since.
  • Cornerstone Planning Group's Insmed position peaked at $8.37K in Q1 2026.
  • 312 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Cornerstone Planning Group's 13F filing for Q2 2026, filed 29 Jul 2026.